Cargando…

The Mouse Uterotrophic Assay: Other End Points

Detalles Bibliográficos
Autor principal:	Newbold, RR
Formato:	Texto
Lenguaje:	English
Publicado:	2001
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1240523/ https://www.ncbi.nlm.nih.gov/pubmed/11776952

Ejemplares similares

The Rodent Uterotrophic Assay: Response to Ashby and Newbold et al.
por: Markey, CM
Publicado: (2001)

Immature rat uterotrophic assay of bisphenol A.
por: Yamasaki, K, et al.
Publicado: (2000)

Sensitivity of the immature rat uterotrophic assay to mixtures of estrogens.
por: Tinwell, Helen, et al.
Publicado: (2004)

The mouse uterotrophic assay: a reevaluation of its validity in assessing the estrogenicity of bisphenol A.
por: Markey, C M, et al.
Publicado: (2001)

Increasing the sensitivity of the rodent uterotrophic assay to estrogens, with particular reference to bisphenol A.
por: Ashby, J
Publicado: (2001)

Estradiol-type activity of coumestrol in mature and immature ovariectomized rat uterotrophic assays.
por: Tinwell, H, et al.
Publicado: (2000)

Predictive value of the uterotrophic assay for genistein carcinogenicity in the neonatal mouse: relevance to infants consuming soy-based formula.
por: Ashby, J, et al.
Publicado: (2001)

Uterotrophic activity of bisphenol A in the immature rat.
por: Ashby, J, et al.
Publicado: (1998)

A Curated Database of Rodent Uterotrophic Bioactivity
por: Kleinstreuer, Nicole C., et al.
Publicado: (2015)

Uterotrophic activity of a "phytoestrogen-free" rat diet.
por: Ashby, J, et al.
Publicado: (2000)

The OECD program to validate the rat uterotrophic bioassay: an overview.
por: Owens, William, et al.
Publicado: (2003)

Ginkgo biloba extract (EGb761) did not express estrogenic activity in an immature rat uterotrophic assay
por: Moon, Byeonghak, et al.
Publicado: (2018)

Correspondence: Confirmation of Uterotrophic Activity for 4-MBC in the Immature Rat
por: Ashby, J
Publicado: (2001)

Key Learnings from the Endocrine Disruptor Screening Program (EDSP) Tier 1 Rodent Uterotrophic and Hershberger Assays
por: Marty, M Sue, et al.
Publicado: (2014)

Increases in mouse uterine heat shock protein levels are a sensitive and specific response to uterotrophic agents.
por: Papaconstantinou, Andriana D, et al.
Publicado: (2002)

Surrogate end points and their role in clinical trial
por: Jaykaran,
Publicado: (2009)

Applying Desirability of Outcome Ranking End Points
por: Dunne, Michael W, et al.
Publicado: (2023)

Confirmation of uterotrophic activity of 3-(4-methylbenzylidine)camphor in the immature rat.
por: Tinwell, Helen, et al.
Publicado: (2002)

The intact immature rodent uterotrophic bioassay: possible effects on assay sensitivity of vomeronasal signals from male rodents and strain differences.
por: Ashby, John, et al.
Publicado: (2003)

Surrogate end points and their role in clinical trials: Reply from authors
por: Kalikar, M.V., et al.
Publicado: (2009)

The OECD program to validate the rat uterotrophic bioassay. Phase 2: dose-response studies.
por: Kanno, Jun, et al.
Publicado: (2003)

The OECD program to validate the rat uterotrophic bioassay. Phase 2: dietary phytoestrogen analyses.
por: Owens, William, et al.
Publicado: (2003)

Fructus Ligustri Lucidi modulates estrogen receptor expression with no uterotrophic effect in ovariectomized rats
por: Tang, Yu-qing, et al.
Publicado: (2018)

The OECD program to validate the rat uterotrophic bioassay. Phase 2: coded single-dose studies.
por: Kanno, Jun, et al.
Publicado: (2003)

Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections
por: Dunne, Michael W, et al.
Publicado: (2023)

The OECD program to validate the rat uterotrophic bioassay to screen compounds for in vivo estrogenic responses: phase 1.
por: Kanno, J, et al.
Publicado: (2001)

The mixture effect of propyl paraben and bisphenol A on the uterotrophic response in the ovariectomized rats after oral administration
por: Park, Juyoung, et al.
Publicado: (2023)

Who should be responsible for the care of advanced chronic kidney disease? Do the guidelines point to the end of nephrology follow-up of advanced CKD or are they the starting point for a new approach?
por: Piccoli, Giorgina Barbara
Publicado: (2020)

Proteomics Complementation of the Rat Uterotrophic Assay for Estrogenic Endocrine Disruptors: A Roadmap of Advancing High Resolution Mass Spectrometry-Based Shotgun Survey to Targeted Biomarker Quantifications
por: Prokai, Laszlo, et al.
Publicado: (2021)

End points for biomonitoring: assay sensitivity/selectivity.
por: Aaron, C S, et al.
Publicado: (1996)

Comment on “Effects of in Utero Exposure to Arsenic during the Second Half of Gestation on Reproductive End Points and Metabolic Parameters in Female CD-1 Mice”
por: Williams, Amy L., et al.
Publicado: (2016)

Response to “Comment on ‘Effects of in Utero Exposure to Arsenic during the Second Half of Gestation on Reproductive End Points and Metabolic Parameters in Female CD-1 Mice’”
por: Rodriguez, Karina F., et al.
Publicado: (2016)

Use of the Correlation Coefficient to Compare a Point-of-Care Antigen Test Against a Quantitative Sandwich Enzyme-Linked Immunosorbent Assay for the Detection of Cryptococcal Meningitis
por: Lee, Sue J., et al.
Publicado: (2012)

Hypolipidemia and Sepsis: It is The Hypolipidemia Not The Statins
por: Elmehdawi, RR
Publicado: (2008)

Points from Letters
Publicado: (1947)

Points from Letters
Publicado: (1949)

Knowledge and Attitude towards Asbestos Hazards among Asbestos Workers in India
por: Tiwari, RR, et al.
Publicado: (2015)

Identification of stem cell units in the terminal end bud and duct of the mouse mammary gland
por: Kenney, Nicholas J, et al.
Publicado: (2001)

End-of-2021 stocktake update
por: Weightman, Michael, et al.
Publicado: (2022)

End-of-2022 stocktake update
por: Weightman, Michael, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_8nnm8rrtamqnuna0ieqg5mpf5t